Mark Asbury
General Counsel, Pharmacyclics.
Companies
- PharmacyclicsGeneral counsel Jul 6, 2011 to May 2, 20121
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Recent filings
- Mar 2, 2022Shares withheld for tax 1,680 shares at $5.38 of Allakos Inc.2
- Feb 25, 2022Granted 140,490 shares of Allakos Inc.3
- Dec 1, 2021Granted 26,003 shares of Allakos Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPharmacyclics, General counsel
- 2SEC EDGARForm 4 filed Mar 3, 2022
- 3SEC EDGARForm 4 filed Mar 1, 2022
- 4SEC EDGARForm 4 filed Dec 3, 2021